bioRxiv · 10.64898/2026.05.01.722324
Therapeutic targeting of fibrin-microglia interactions ameliorates Alzheimer disease-related hyperexcitability and brain network dysfunction
Abstract
Brain network dysfunction--including hyperexcitability, altered oscillations, and sleep disruption--is prominent in Alzheimers disease (AD), but the contribution of vascular-neuroimmune processes to these alterations remains unclear. Here, we blocked the pro-inflammatory interaction of the blood protein fibrin with microglia using genetic (Fgg{gamma}390-396A mice) and antibody-based (5B8 and THN392) strategies to test its role in AD-related network dysfunction. The 5xFAD model of AD exhibited network hyperexcitability associated with oscillatory slowing, sleep states, and disrupted sleep-circadian rhythms. These deficits were largely attenuated by blocking fibrin-microglia interactions in 5xFAD;Fgg{gamma}390-396A mice. Notably, pharmacological interventions after disease onset with both anti-fibrin antibodies similarly attenuated these AD-related network deficits and behavioral abnormalities. We conclude that vascular-neuroimmune processes driven by fibrin-microglia interactions promote AD-related network dysfunction and that targeting the fibrin-microglia axis--currently under clinical evaluation with the humanized antibody THN391-- represents a promising therapeutic strategy for AD. There is a companion manuscript submitted to bioRxiv (Yan et al., 2026).110 HIGHLIGHTSO_LIFibrin promotes AD-related network hyperexcitability and oscillatory slowing in 5xFAD mice C_LIO_LIFibrin promotes AD-related disruption of sleep and circadian rhythms in 5xFAD mice C_LIO_LIGenetic blocking of fibrin-microglia interactions rescues AD-related brain network dysfunction C_LIO_LIAnti-fibrin antibodies (5B8 and THN392) show acute and chronic therapeutic benefit C_LI
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Lauderdale, K., Yan, Z., Mendiola, A. S., Zhang, Y., Mallen, D., Nambiar, P., Brady, E., Miller, S. R., Acevedo, R. M., Cabriga, B., Jiang, F., Kaliss, N., Shen, K., Shin, J., Herbert, J., Ma, K., Ryu, J. K., Agrawal, A., Schuck, R., Alzamora, M. d. P. S., Sanz-Ros, J., Cobos, I., Stavenhagen, J., Kantor, A. B., Ellisman, M. H., Akassoglou, K., Palop, J. J.. 2026-05-06. Therapeutic targeting of fibrin-microglia interactions ameliorates Alzheimer disease-related hyperexcitability and brain network dysfunction. https://doi.org/10.64898/2026.05.01.722324
Cite the original work for its findings. Save a collection to share your selection of sources.